about
Practice nurses and pharmacists: a perspective on the expectation and experience of nurses for future collaboration.In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes.Development and evaluation of hydrophilic colloid matrix of famotidine tablets.Development of enteric coated flurbiprofen tablets using Opadry/Acryl-Eze system--a technical note.Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery.Electrochemical performance of 2D polyaniline anchored CuS/Graphene nano-active composite as anode material for lithium-ion battery.Cardiovascular Disease Risk Associated With the Long-term Use of Depot Medroxyprogesterone Acetate.Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.Development of in vitro - in vivo correlations for newly optimized Nimesulide formulationsComparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS methodAceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristicsLornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancersClay nanotubes as a novel multifunctional excipient for the development of directly compressible diclofenac potassium tablets in a SeDeM driven QbD environmentComparative pharmacokinetic evaluation of extended release itopride HCl pellets with once daily tablet formulation in healthy human subjects: a two treatment, four period crossover study in fasted and fed condition
P50
Q34064455-830704CD-420F-4918-B952-DAE69D6E7B81Q38846402-CDED4CC5-CEB4-4373-BECF-89601E62A2FEQ41988884-858C1A82-DA43-46DB-9CE1-B2376C9EADA0Q41989717-D4B0D3DB-469D-45D5-8140-2F4CA82D2070Q42291896-0EAEE9F5-B7F6-4421-BD42-0A5651F83C83Q42705880-CD942594-E540-4D3C-9067-4E5C8620C4E0Q50202428-C2438B1A-690F-45FC-8395-893B89888996Q51276121-E72BD7D2-3655-4617-B9CF-874AC12E4233Q55434724-899E19FD-34B5-4E09-99D5-40D833B990BBQ58782466-AD25E7E7-9244-43AE-82F5-5929264FE979Q89556484-1374CB99-F358-4EFC-A234-340E6FBA2BB3Q89681200-E240346C-5ED5-415E-814F-6ACF7789DC92Q89927192-09FF77DF-5B88-408D-A32A-1994A1FDC80AQ92879076-E1E4B40E-3663-46A5-9067-83A37C09A4FFQ93234781-963A6FD0-E0C9-4074-8376-D727152C594D
P50
description
researcher ORCID ID = 0000-0002-3639-0026
@en
wetenschapper
@nl
name
Muhammad Harris Shoaib
@ast
Muhammad Harris Shoaib
@en
Muhammad Harris Shoaib
@es
Muhammad Harris Shoaib
@nl
type
label
Muhammad Harris Shoaib
@ast
Muhammad Harris Shoaib
@en
Muhammad Harris Shoaib
@es
Muhammad Harris Shoaib
@nl
prefLabel
Muhammad Harris Shoaib
@ast
Muhammad Harris Shoaib
@en
Muhammad Harris Shoaib
@es
Muhammad Harris Shoaib
@nl
P106
P31
P496
0000-0002-3639-0026